Clinical Trials
59 trialsLymphovenous Bypass Procedure Before Underarm Lymph Node Surgery in Preventing Lymphedema in Patients With Inflammatory or Locally Advanced Non-inflammatory Breast Cancer or Melanoma
M.D. Anderson Cancer Center
High Dose-Rate Brachytherapy for the Treatment of Both Primary and Secondary Unresectable Liver Malignancies
M.D. Anderson Cancer Center
VERDI
Dana-Farber Cancer Institute
FOCUS
Ohio State University Comprehensive Cancer Center
Exploratory Study With Parallel Controls on the Safety and Efficacy of Neoadjuvant Low Branched-Chain Amino Acid Diet in Combination With Anti-PD-1 Monoclonal Antibody for Stage III Melanoma
Xijing Hospital
Improving Adolescent and Young Adult Self-Reported Data in ECOG-ACRIN Trials
Eastern Cooperative Oncology Group
Pilot Study of Bone Mineral Density Changes During Anti-PD-1 Immunotherapy
Vanderbilt-Ingram Cancer Center
SPRINT
Universitätsklinikum Hamburg-Eppendorf
Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
Stanford University
MSLT-3
Melanoma Institute Australia
Cryoablation Combined With Stereotactic Body Radiation Therapy for the Treatment of Painful Bone Metastases, the CROME Trial
M.D. Anderson Cancer Center
Electrochemotherapy (ECT) in Patients With Primary Visceral Tumors and/or Secondary Visceral Localizations, of Any Histotype
Istituto Oncologico Veneto IRCCS
High-Intensity Exercise and High-Fiber Diet for Immunotherapy Outcomes in Melanoma Patients: The DUO Trial
Fred Hutchinson Cancer Center
A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue
Memorial Sloan Kettering Cancer Center
RESPECT
Universität Duisburg-Essen
MEL
Institute of Health Information and Statistics of the Czech Republic
CURB-Melanoma
University Health Network, Toronto
PRIME-LRT
University of Cincinnati
MySmartSkin Online Skin Self-exam Intervention for Melanoma Survivors
Rutgers, The State University of New Jersey
The Florida ASCENT Study
University of Florida
MAK
Institute of Oncology Ljubljana
Electrochemotherapy-Induced Changes in Tumor Microenvironment in Cutaneous Melanoma
Institute of Oncology Ljubljana
IT-TCP POS
Azienda Ospedaliero-Universitaria di Parma
Efficacy of First-Line Immunotherapy in Metastatic Melanoma in Slovenia and Identification of Predictive Biomarkers
Institute of Oncology Ljubljana
Studying Quality of Life Inclusive of Mental Health and Cognitive Behavioral Therapy for Cancer Distress for the Improvement of Quality of Life in Stage III-IV Melanoma Patients
Mayo Clinic
MitoCancer
Goethe University
MEL-META
Centre Hospitalier Universitaire de Nice
LONGSAFE
Miltenyi Biomedicine GmbH
Immunobiome
University of Aarhus
Beta Glucan's Effect on Pembrolizumab Immunologic Response in Stage III-IV Melanoma
University of Louisville
IMPROVE
Memorial Sloan Kettering Cancer Center
MELFIB
University Medical Center Groningen
EXCILYNT
University of Virginia
OMIT
Erasmus Medical Center
DP-PAN-CANCER
Institut Claudius Regaud
Anti PD-1 Plus Postbiotic Versus Anti PD-1 Alone in Locally Advanced or Metastatic, Treatment naïve, Cutaneous Melanoma Study
Azienda Ospedaliera di Perugia
Melanoma SCP
Erasmus Medical Center
EPITHEM
Assistance Publique - Hôpitaux de Paris
TEP-ANTI-PD1
Centre Hospitalier Universitaire de Nice
Cytophone
Cytoastra
PROMMEL
Karolinska University Hospital
WoW
Vastra Gotaland Region
Safe Stop Ipilimumab-nivolumab (IPI-NIVO) Trial
Erasmus Medical Center
RAYS
University of Utah
TRIM
Uppsala University
MelMarT-II
Melanoma and Skin Cancer Trials Limited
DermaSensor Postmarket Surveillance Study
DermaSensor, Inc.
NANOSCAN
The Netherlands Cancer Institute
Biomarkers in Immunotherapy of Melanoma
Institute of Oncology Ljubljana
MONITOR
Hospices Civils de Lyon